Search Results - "Al-Rajabi R"

Calciphylaxis as a Rare Complication Associated with Pemigatinib Treatment—A Case Report.

Authors: Čular, Katarina Hamzić, Dora Tomek Smiljanić Tomičević, Ljiljana et al.

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p360. 8p.

Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.

Authors: Chakrabarti, Sakti Cohen, Stacey A. Tin, Antony et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p589. 17p.

Significant Correlation of Dynamic Pan-Immune Inflammation Value and Magnetic Resonance Imaging Response in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy.

Authors: Celikarslan, Sukran Karahacioglu, Duygu Gurses, Bengi et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p278. 16p.

The Diagnostic Value of Deep Learning for Multi-Classification of Rectal Cancer T Staging Based on Regional Attention.

Authors: Qiu, Chenyang Xia, Yihui Feng, Zhiguo et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 10, p1525. 19p.

First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice.

Authors: Maruki, Yuta Morizane, Chigusa Okada, Mao et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5586. 6p.

Expression Profiles and Biomarker Potential of Long Non-Coding RNAs H19, NEAT1, MALAT1 and HOTAIR in Locally Advanced Rectal Cancer Patients.

Authors: Eric, Katarina Rosic Stojkovic, Jovana Miladinov, Marko et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 4, p1672. 16p.

Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic Mimickers.

Authors: Suzuki, Shuhei Seino, Manabu Sato, Hidenori et al.

Source: Pharmaceuticals (14248247). Feb2026, Vol. 19 Issue 2, p311. 14p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024.

Authors: Leigh, Jennifer Ahmed, Arwa Aubin, Francine et al.

Source: Current Oncology. Mar2025, Vol. 32 Issue 3, p175. 17p.

A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma.

Authors: Lei, Fangyong Deng, Wenjing Zhou, Ying et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p88. 18p.

The Role of Organ Sparing Approaches After Total Neoadjuvant Treatment in Rectal Cancer.

Authors: Rizzo, Gianluca Tondolo, Vincenzo Amodio, Luca Emanuele et al.

Source: Cancers. Jan2026, Vol. 18 Issue 1, p55. 14p.

Radiopathological Correlation in Locally Advanced Rectal Cancer After Neoadjuvant Treatment.

Authors: Martín-Sánchez, Mario Villarejo Campos, Pedro Domínguez-Prieto, Víctor et al.

Source: Cancers. Dec2025, Vol. 17 Issue 24, p3937. 13p.

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer.

Authors: Groszewska, Julia Romaniuk, Michał Małecka-Wojciesko, Ewa

Source: International Journal of Translational Medicine. Dec2025, Vol. 5 Issue 4, p55. 24p.

Non-Operative Management (NOM) in Rectal Cancer: Current Evidence and Future Directions.

Authors: Schiavone, Vincenzo Capolupo, Gabriella Teresa Mascianà, Gianluca et al.

Source: Encyclopedia. Dec2025, Vol. 5 Issue 4, p165. 8p.

Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers.

Authors: Capuozzo, Maurizio Picone, Carmine Sabbatino, Francesco et al.

Source: Cancers. Nov2025, Vol. 17 Issue 21, p3438. 44p.

Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17–18 October 2024.

Authors: Ravi, Deepti Ahmed, Shahid Anderson, Blaire et al.

Source: Current Oncology. Jul2025, Vol. 32 Issue 7, p398. 18p.

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma.

Authors: Satake, Tomoyuki Morizane, Chigusa Isayama, Hiroyuki et al.

Source: Hepatology Research. Jul2025, Vol. 55 Issue 7, p1005-1014. 10p.

Does Total Neoadjuvant Therapy Impact Surgical Precision in Total Mesorectal Excision? A Nationwide Survey of the Experiences of Expert Surgeons.

Authors: Jäger, Tarkan Zitt, Matthias Riss, Stefan et al.

Source: Cancers. Jan2025, Vol. 17 Issue 2, p283. 18p.

PARP Inhibitors in Pancreatic Cancer with Homologous Recombination Repair Gene Mutations: A Single-Institution Experience.

Authors: Miao, Ruoyu Blue, Kirsten Sommerer, Katelyn et al.

Source: Cancers. Oct2024, Vol. 16 Issue 20, p3447. 11p.

Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.

Authors: Cousin, Sophie Guégan, Jean-Philippe Shitara, Kohei et al.

Source: Molecular Cancer. 9/13/2024, Vol. 23 Issue 1, p1-11. 11p.

A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.

Authors: Kasi A Gaudel P Lekkala M et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2023 Dec; Vol. 29 (8), pp. 1951-1956. Date of Electronic Publication: 2023 Mar 07.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE